Prostate Screening: UK Industry Body Explores Role In Study, Points To Growing Diagnostics Remit

ABHI promises more activity to support early diagnosis and population health management

15 Feb 2024

Early diagnosis information is central to disease detection and will reduce treatment costs overall, says Nishan Sunthares, who heads the Association of British HealthTech Industries’ work on diagnostic technologies including IVDs.

In fall 2023, the charity Prostate Cancer UK announced it will lead a major screening program starting this year. With funding of £42m ($53m), including a government contribution of £16m, the Transform study is described as the biggest UK prostate cancer diagnosis trial in 20 years. It will begin recruiting in fall 2024.

Transform will investigate promising tests with a goal of providing definitive evidence on the best ways to screen for prostate...